Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Glenmark Life Sciences’ Q1FY25 results shock industry with 9.7% revenue surge
Glenmark Life Sciences Limited (BSE: 543322, NSE: GLS), a prominent player in the pharmaceutical industry, has announced impressive financial results for the quarter ended June ... Read More
Sun Pharmaceutical bags LEQSELVI FDA approval for severe alopecia areata
In a significant development for the treatment of severe alopecia areata, Sun Pharmaceutical Industries Limited has announced that the U.S. Food and Drug Administration (FDA) ... Read More
Johnson & Johnson seeks FDA approval for SPRAVATO in treatment-resistant depression
Johnson & Johnson (NYSE: JNJ) is seeking U.S. Food and Drug Administration (FDA) approval for SPRAVATO (esketamine) as a standalone treatment for adults with treatment-resistant ... Read More
Rossari Biotech shocks market with stellar Q1 FY25 performance – Revenues soar by 19.3%
Rossari Biotech Limited, a prominent specialty-chemicals manufacturer, has unveiled its financial results for the quarter ending June 30, 2024, showcasing significant year-on-year growth across key ... Read More
UK MHRA approves first generic raltegravir medicines for HIV treatment
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for the first generic raltegravir medicines, designed to treat adult and pediatric HIV ... Read More
$35 million boost for Rona Therapeutics: A new era in RNA medicine begins!
Rona Therapeutics, a clinical-stage company leading the way in nucleic acid drug research and development, has successfully completed a Series A+ financing round, raising $35 ... Read More
Breakthrough in diabetes care: Roche’s Susvimo could revolutionize eye treatment
Roche, a global leader in pharmaceuticals and diagnostics, recently unveiled two-year data from the pivotal Phase III Pagoda and Pavilion studies, showcasing the sustained efficacy ... Read More
Exscientia takes full ownership of cdk7 inhibitor in oncology breakthrough
Exscientia plc (Nasdaq: EXAI), a pioneer in AI-driven drug discovery, has reached a strategic milestone by acquiring full ownership of the oral CDK7 inhibitor program ... Read More
Sermonix Pharmaceuticals awarded U.S. patent for lasofoxifene in breast cancer treatment
Sermonix Pharmaceuticals Inc., a leader in biopharmaceutical innovations, has achieved a significant milestone with the issuance of a new U.S. patent that broadens the application ... Read More
Marinus Pharmaceuticals announces NMPA approval of Ganaxolone for CDKL5 deficiency disorder
Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a leader in developing innovative therapeutics for seizure disorders, has achieved a significant milestone with the approval of its ganaxolone oral ... Read More